CANY
RDY icon

Caxton Associates (New York)’s Dr. Reddy's Laboratories RDY Stock Holding History

Caxton Associates (New York)’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-67,595
Closed -$753K – 719
2022
Q1 		$753K Buy
+67,595
New +$766K 0.07% 153
2021
Q3 		– Sell
-14,915
Closed -$219K – 583
2021
Q2 		$219K Buy
+14,915
New +$209K 0.03% 403
2014
Q1 		– Sell
-44,500
Closed -$365K – 261
2013
Q4 		$365K Buy
+44,500
New +$352K 0.03% 198

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $528B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM